9219 POSTER Combined Modality Therapy for Stage l-ll Diffuse Large B-cell Lymphoma Provides Excellent Local Control and Clinical Outcome in the Rituximab Era

2011 ◽  
Vol 47 ◽  
pp. S644-S645 ◽  
Author(s):  
L. Lao ◽  
R. Tsang ◽  
M. Pintilie ◽  
J. Skliarenko ◽  
D. Hodgson ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
B Cell ◽  
Local Control ◽  
Cell Lymphoma ◽  
Combined Modality Therapy ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Combined Modality ◽  
Large B Cell

scholarly journals Concomitant statin use does not impair the clinical outcome of patients with diffuse large B cell lymphoma treated with rituximab-CHOP

2010 ◽  
Vol 89 (8) ◽  
pp. 783-787 ◽  
Author(s):  
Panagiotis Samaras ◽  
Helen Heider ◽  
Sarah R. Haile ◽  
Ulf Petrausch ◽  
Niklaus G. Schaefer ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Large B Cell Lymphoma ◽  
Large B Cell ◽  
Statin Use

Serum soluble Fas level determines clinical outcome of patients with diffuse large B-cell lymphoma treated with CHOP and R-CHOP

2009 ◽  
Vol 135 (10) ◽  
pp. 1421-1428 ◽  
Author(s):  
Takeshi Hara ◽  
Hisashi Tsurumi ◽  
Naoe Goto ◽  
Nobuhiro Kanemura ◽  
Takeshi Yoshikawa ◽  
...  
Keyword(s):  
Clinical Outcome ◽  
B Cell ◽  
Cell Lymphoma ◽  
B Cell Lymphoma ◽  
Soluble Fas ◽  
Large B Cell Lymphoma ◽  
Large B Cell
Sign in / Sign up

Export Citation Format

Share Document